APOLIPOPROTEIN-L, A NEW HUMAN HIGH-DENSITY-LIPOPROTEIN APOLIPOPROTEINEXPRESSED BY THE PANCREAS - IDENTIFICATION, CLONING, CHARACTERIZATION, AND PLASMA DISTRIBUTION OF APOLIPOPROTEIN-L
Pn. Duchateau et al., APOLIPOPROTEIN-L, A NEW HUMAN HIGH-DENSITY-LIPOPROTEIN APOLIPOPROTEINEXPRESSED BY THE PANCREAS - IDENTIFICATION, CLONING, CHARACTERIZATION, AND PLASMA DISTRIBUTION OF APOLIPOPROTEIN-L, The Journal of biological chemistry, 272(41), 1997, pp. 25576-25582
In this study, we have identified and characterized a new protein pres
ent in human high density lipoprotein that we have designated apolipop
rotein L. Using a combination of liquid-phase isoelectrophoresis and h
igh resolution two-dimensional gel electrophoresis, apolipoprotein L w
as identified and partially sequenced from immunoisolated high density
lipoprotein (Lp(A-I)). Expression was only detected in the pancreas,
The cDNA sequence encoding the full-length protein was cloned using re
verse transcription-polymerase chain reaction, The deduced amino acid
sequence contains 383 residues, including a typical signal peptide of
12 amino acids, No significant homology was found with known sequences
, The plasma protein is a single chain polypeptide with an apparent mo
lecular mass of 42 kDa, Antibodies raised against this protein detecte
d a truncated form with a molecular mass of 39 kDa, Both forms were pr
edominantly associated with immunoaffinity-isolated apoA-I-containing
lipoproteins and detected mainly in the density range 1.123 < d < 1.21
g/ml. Free apoL was not detected in plasma. Anti-apoL immunoaffinity
chromatography was used to purify apoL-containing lipoproteins (Lp(L))
directly from plasma. Nondenaturing gel electrophoresis of Lp(L) show
ed two major molecular species with apparent diameters of 12.2-17 and
10.4-12.2 nm. Moreover, Lp(L) exhibited both pre-beta and alpha electr
omobility. Apolipoproteins A-I, A-II, A-IV, and C-III were also detect
ed in the apoL-containing lipoprotein particles.